141 related articles for article (PubMed ID: 32807812)
1. Integrated [
Tsujikawa T; Oikawa H; Tasaki T; Hosono N; Tsuyoshi H; Rahman MGM; Yoshida Y; Yamauchi T; Kimura H; Okazawa H
Sci Rep; 2020 Aug; 10(1):13878. PubMed ID: 32807812
[TBL] [Abstract][Full Text] [Related]
2. Whole-body bone marrow DWI correlates with age, anemia, and hematopoietic activity.
Tsujikawa T; Oikawa H; Tasaki T; Hosono N; Tsuyoshi H; Yoshida Y; Yamauchi T; Kimura H; Okazawa H
Eur J Radiol; 2019 Sep; 118():223-230. PubMed ID: 31439246
[TBL] [Abstract][Full Text] [Related]
3. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
4. A bone marrow F-18 FDG uptake exceeding the liver uptake may indicate bone marrow hyperactivity.
Inoue K; Goto R; Okada K; Kinomura S; Fukuda H
Ann Nucl Med; 2009 Sep; 23(7):643-9. PubMed ID: 19629627
[TBL] [Abstract][Full Text] [Related]
5. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
6. Bone Marrow Involvement in Malignant Lymphoma: Evaluation of Quantitative PET and MRI Biomarkers.
Asenbaum U; Nolz R; Karanikas G; Furtner J; Woitek R; Simonitsch-Klupp I; Raderer M; Mayerhoefer ME
Acad Radiol; 2018 Apr; 25(4):453-460. PubMed ID: 29199055
[TBL] [Abstract][Full Text] [Related]
7. Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI.
Zambello R; Crimì F; Lico A; Barilà G; Branca A; Guolo A; Varin C; Vezzaro R; Checuz L; Scapin V; Berno T; Pizzi M; Ponzoni A; De Biasi E; Vio S; Semenzato G; Zucchetta P; Lacognata C
Ann Hematol; 2019 Mar; 98(3):679-689. PubMed ID: 30539276
[TBL] [Abstract][Full Text] [Related]
8. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
Albano D; Patti C; Lagalla R; Midiri M; Galia M
J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
[TBL] [Abstract][Full Text] [Related]
9. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging based bone marrow segmentation for quantitative calculation of pure red marrow metabolism using 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography: a novel application with significant implications for combined structure-function approach.
Basu S; Houseni M; Bural G; Chamroonat W; Udupa J; Mishra S; Alavi A
Mol Imaging Biol; 2007; 9(6):361-5. PubMed ID: 17899296
[TBL] [Abstract][Full Text] [Related]
11. Age-related changes in the metabolic activity and distribution of the red marrow as demonstrated by 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography.
Fan C; Hernandez-Pampaloni M; Houseni M; Chamroonrat W; Basu S; Kumar R; Dadparvar S; Torigian DA; Alavi A
Mol Imaging Biol; 2007; 9(5):300-7. PubMed ID: 17574502
[TBL] [Abstract][Full Text] [Related]
12. Correlation of bone marrow 2-deoxy-2-[ 18 F]fluoro-D-glucose uptake with systemic inflammation in patients with newly diagnosed endometrial cancer.
Ishibashi M; Norikane T; Yamamoto Y; Imajo M; Takami Y; Mitamura K; Tanaka T; Tsuruta T; Kanenishi K; Nishiyama Y
Nucl Med Commun; 2022 Aug; 43(8):916-921. PubMed ID: 35634809
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection.
Lee JW; Na JO; Kang DY; Lee SY; Lee SM
Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385
[TBL] [Abstract][Full Text] [Related]
14. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma.
Ak I; Gulbas Z
Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019
[TBL] [Abstract][Full Text] [Related]
15. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
Acta Radiol; 2015 Oct; 56(10):1230-5. PubMed ID: 25387723
[TBL] [Abstract][Full Text] [Related]
16. Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?
Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
Nucl Med Commun; 2016 Jan; 37(1):23-9. PubMed ID: 26440567
[TBL] [Abstract][Full Text] [Related]
17. Positron Emission Tomography-based Analysis Can Accurately Predict Bone Marrow Involvement With Mantle Cell Lymphoma.
Morgan R; Perry M; Kwak J; Jensen A; Kamdar M
Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):731-736. PubMed ID: 30075973
[TBL] [Abstract][Full Text] [Related]
18. Physiological uptake of 18F-FDG in the vertebral bone marrow in healthy adults on PET/CT imaging.
Shen G; Liang M; Su M; Kuang A
Acta Radiol; 2018 Dec; 59(12):1487-1493. PubMed ID: 29486597
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric analysis of bone marrow in cancer patients using simultaneous PET/MR imaging: Correlation of fat fraction, diffusivity, metabolic activity, and anthropometric data.
Schraml C; Schmid M; Gatidis S; Schmidt H; la Fougère C; Nikolaou K; Schwenzer NF
J Magn Reson Imaging; 2015 Oct; 42(4):1048-56. PubMed ID: 25683203
[TBL] [Abstract][Full Text] [Related]
20. Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies.
Teo BK; Badiee S; Hadi M; Lam T; Johnson L; Seo Y; Bacharach SL; Hasegawa BH; Franc BL
Nucl Med Commun; 2008 Apr; 29(4):359-66. PubMed ID: 18317301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
